Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002012383-25-002853·BlackRock, Inc.
Schedule 13G ownership disclosure
Corvus Pharmaceuticals Inc
Common Stock · CUSIP: 221015100
Event date: 2025-09-30
- Filing-level shares
- 4,015,510
- Percent of class
- 5.4%
- BlackRock, Inc.
Shares: 4,015,510 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-002853
- Form type
- SCHEDULE 13G
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Oct 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership